Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Insight Public Affairs

We are an award winning 15-strong team of consultants able to offer extensive experience in politics, government, media and stakeholder engagement, across a breadth of policy areas including telecoms, technology, gambling, life sciences, financial services, housing, infrastructure, copyright, employment, media and advertising, food and drink, social care, retail, and education. As an independent agency we go that extra mile to deliver results-focussed communications strategies and programmes that fulfil our clients’ commercial imperatives. Working tirelessly to meet our clients’ goals, we are a team who understand client challenges, develop bespoke strategies and programmes, and meet these strategic objectives.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

- PMLiVE

Visions4Health

Visions4Health are market access experts and your gateway to local adoption at pace. Leveraging our lived experience, understanding of national and local healthcare systems, and insights generated by our stakeholder…

View Profile

Health policy and government affairs, Market access, Market research

Company Details

Insight Public Affairs
52 Grosvenor Gardens, London, SW1W 0AU, United Kingdom
+44 (0)20 7824 1865
Contact Insight Public Affairs
Website

 Latest Content from PMHub 

We’re now a B Corp!

Press Releases | February 16, 2024 | Wallace Health

PRESS RELEASE: Wallace Health has been certified as B Corporation, a business that pursues purpose as well as profit.

Wallace Health becomes an accredited PIF TICK member

Press Releases | February 16, 2024 | Wallace Health

PRESS RELEASE: Wallace Health gains PIF TICK accreditation to become a ‘trusted information creator’

6 content must-dos for 2024

Press Releases | February 16, 2024 | Wallace Health

What are the key trends and innovations that will shape the way we create health content in 2024?  Here are the six things the Wallace Health team will be focusing on...

5 ways to engage HCPs in medical education

White Papers and Resources | February 16, 2024 | Wiley

How to bring credibility, trust and flexibility into your medical education programs

Navigating challenges of MedTech research with rare-disease patients

White Papers and Resources | February 16, 2024 | Inizio

Authored by: Tom Donnelly, MedTech Director and Amanda Pirraglia, Associate Director. Published in Quirk's Magazine.

Did You Hear From Her? If Not Here’s What You Missed in Season 1 of the Award-Winning Season Podcast Series

Press Releases | February 15, 2024 | Medscape Education

What are some of the biggest gaps that women face in healthcare today?  “So many I could talk for hours!” said Shikha Jain, MD, FACP, President, CEO, Founder Women in Medicine....

Have you heard from her?

Press Releases | February 15, 2024 | Medscape Education

We’re referring to the renowned women leaders from across the healthcare landscape who were our guests on Season 1 of Medscape Education’s Hear From Her podcast series. The conversations touched...

Clinical trial considerations: Why diversity matters…

White Papers and Resources | February 15, 2024 | Cuttsy + Cuttsy

Diversity in clinical trials is crucial for understanding diseases and developing new treatments. Here's why diversity matters...

Rare Disease Diagnostic Odyssey

Videos and Podcasts | February 14, 2024 | Medscape Education

Rare disease market access – Launching orphan drugs in secondary markets: the Nordic and MENA regions

Press Releases | February 14, 2024 | Petauri Evidence

Join us live at 1.00pm (GMT)/2.00pm (CET)/8.00am (EST) on Thursday 29th February, to explore rare disease market access challenges and learn more about these high potential markets.